Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other financing activities (2024)

Catalyst Pharmaceuticals (CPRX) has disclosed Other financing activities for 1 consecutive years, with $296000.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $296000.0, compared with a TTM value of $296000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $296000.0, changed N/A over the prior year.
  • Other financing activities was $296000.0 for Q1 2024 at Catalyst Pharmaceuticals.
  • Across five years, Other financing activities topped out at $296000.0 in Q1 2024 and bottomed at $296000.0 in Q1 2024.